November 20,2007
Grassley, Baucus seek information from former drug company executive in Avandia case
WASHINGTON — Sens. Chuck Grassley and Max Baucus have asked a former drug company research executive to provide information to the Senate Committee on Finance about attempts to intimidate a prominent independent scientist who voiced concerns about drug safety.
Dr. Tadataka Yamada was formerly the head of research at GlaxoSmithKline. He now heads the Global Health Program at the Bill and Melinda Gates Foundation. Dr. John Buse was a professor of medicine at the University of North Carolina in 1999, when he expressed concerns about the diabetes drug Avandia, which is made by GlaxoSmithKline.
###
Next Article Previous Article
Recent News
- Wyden, Schumer, Warren Sound Alarm Over Trump Weaponization of the IRS Against the Free Speech Rights of Trump Opponents
- Finance Democrats Call for Halt to Unlawful Nomination of March Bell to be Health Care Inspector General
- Wyden, Welch, Cortez Masto Introduce Bill to Block Republicans’ Big Pharma Bailout, Protect Access to Life-Saving Prescription Drugs
- New CBO Report: Trump's Big Ugly Bill Includes $8.8 Billion Handout for Pharmaceutical Companies
- With JPMorgan Chase Dodging Epstein Inquiry, Wyden Investigation Drills Down On Bank Executives’ Unexplained Conduct